Sort   by:  
 Page size 
UnknownPatient-derived cancer organoid tracking with wide-field one-photon redox imaging to assess treatment response.
Not available
S-EPMC7983069 | biostudies-literature
UnknownA randomized phase 2 trial of nivolumab, gemcitabine, and cisplatin or nivolumab and ipilimumab in previously untreated advanced biliary cancer: BilT-01.
Not available
S-EPMC9540241 | biostudies-literature
UnknownmTOR inhibition elicits a dramatic response in PI3K-dependent colon cancers.
Not available
S-EPMC3621889 | biostudies-literature
UnknownA Systematic Review of Immune Checkpoint Inhibitors in Non-Clear-Cell Renal Cancer.
Not available
S-EPMC9490428 | biostudies-literature
UnknownA phase 2 randomised study of veliparib plus FOLFIRI±bevacizumab versus placebo plus FOLFIRI±bevacizumab in metastatic colorectal cancer.
Not available
S-EPMC6342906 | biostudies-literature
UnknownPIK3CA and APC mutations are synergistic in the development of intestinal cancers.
Not available
S-EPMC3883937 | biostudies-literature
UnknownLive cell molecular analysis of primary prostate cancer organoids identifies persistent androgen receptor signaling.
Not available
S-EPMC8478748 | biostudies-literature
UnknownPreventing dysbiosis of the neonatal mouse intestinal microbiome protects against late-onset sepsis.
Not available
S-EPMC7250008 | biostudies-literature
UnknownMetabolic Syndrome and Acute Respiratory Distress Syndrome in Hospitalized Patients With COVID-19.
Not available
S-EPMC8696573 | biostudies-literature
UnknownBCL-2 Family Inhibition Enhances mTORC1/2 Inhibition in PIK3CA-Mutant Colorectal Cancer.
Not available
S-EPMC12767208 | biostudies-literature
Sort   by:  
 Page size